Medicare Part D Drug Coverage List

According to the Centers for Medicare & Medicaid Services (CMS) 2026 Part D formulary data, this list covers 6,046 drugs across Medicare Part D plans, sorted by how broadly each is covered. Under the Inflation Reduction Act, Part D out-of-pocket costs are capped at $2,000 a year in 2026; see our methodology for how coverage breadth is calculated.

Coverage varies by plan and geography. Verify drug coverage with your specific plan before making decisions.

Overview Browse Drugs Part D Plans Rankings

Drug Name	Plans Covering	Coverage %	Avg Tier	PA %	2023 Benes
cabozantinib 20 MG Oral Tablet [Cabometyx] cabozantinib	5,067	100%	T4	99.4%	8,210
cabozantinib 40 MG Oral Tablet [Cabometyx] cabozantinib	5,067	100%	T4	99.4%	8,210
darunavir 75 MG Oral Tablet [Prezista] darunavir	5,067	100%	T3	0%	8,166
darunavir 150 MG Oral Tablet [Prezista] darunavir	5,067	100%	T4	0%	8,166
darunavir 100 MG/ML Oral Suspension [Prezista] darunavir	5,067	100%	T4	0%	8,166
darunavir 600 MG Oral Tablet darunavir	5,067	100%	T3	0%	8,166
darunavir 800 MG Oral Tablet darunavir	5,067	100%	T4	0%	8,166
loxapine 5 MG Oral Capsule loxapine	5,067	100%	T2	13.6%	8,065
loxapine 10 MG Oral Capsule loxapine	5,067	100%	T2	13.6%	8,065
loxapine 25 MG Oral Capsule loxapine	5,067	100%	T2	13.6%	8,065
loxapine 50 MG Oral Capsule loxapine	5,067	100%	T2	13.6%	8,065
trifluridine 10 MG/ML Ophthalmic Solution trifluridine	5,067	100%	T3	0%	7,948
{30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 4] lenvatinib	5,067	100%	T4	99.4%	7,904
{60 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 8] lenvatinib	5,067	100%	T4	99.4%	7,904
{30 (lenvatinib 10 MG Oral Capsule [Lenvima]) } Pack [Lenvima 10] lenvatinib	5,067	100%	T4	99.4%	7,904
{90 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 12] lenvatinib	5,067	100%	T4	99.4%	7,904
{30 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 14] lenvatinib	5,067	100%	T4	99.4%	7,904
{30 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 60 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 18] lenvatinib	5,067	100%	T4	99.4%	7,904
{60 (lenvatinib 10 MG Oral Capsule [Lenvima]) } Pack [Lenvima 20] lenvatinib	5,067	100%	T4	99.4%	7,904
{60 (lenvatinib 10 MG Oral Capsule [Lenvima]) / 30 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 24] lenvatinib	5,067	100%	T4	99.4%	7,904
ritonavir 100 MG Oral Powder [Norvir] ritonavir	5,067	100%	T3	0%	7,866
ritonavir 100 MG Oral Tablet ritonavir	5,067	100%	T2	0%	7,866
raltegravir 400 MG Oral Tablet [Isentress] raltegravir	5,067	100%	T4	0%	7,475
raltegravir 25 MG Chewable Tablet [Isentress] raltegravir	5,067	100%	T3	0%	7,475
raltegravir 100 MG Chewable Tablet [Isentress] raltegravir	5,067	100%	T4	0%	7,475
raltegravir 600 MG Oral Tablet [Isentress] raltegravir	5,067	100%	T4	0%	7,475
raltegravir 100 MG Granules for Oral Suspension [Isentress] raltegravir	5,067	100%	T4	0%	7,475
sirolimus 1 MG Oral Tablet sirolimus	5,067	100%	T3	100%	7,218
sirolimus 2 MG Oral Tablet sirolimus	5,067	100%	T3	100%	7,218
sirolimus 1 MG/ML Oral Solution sirolimus	5,067	100%	T3	100%	7,218
sirolimus 0.5 MG Oral Tablet sirolimus	5,067	100%	T3	100%	7,218
darolutamide 300 MG Oral Tablet [Nubeqa] darolutamide	5,067	100%	T4	99.4%	7,174
albendazole 200 MG Oral Tablet albendazole	5,067	100%	T3	15.8%	7,118
0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection [Menquadfi] Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine	5,067	100%	T2	1.5%	6,991
timolol 2.5 MG/ML Ophthalmic Solution timolol	5,067	100%	T1	0%	6,978
0.5 ML yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injection [YF-Vax] yellow fever virus strain	5,067	100%	T2	0%	6,969
yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injectable Suspension [YF-Vax] yellow fever virus strain	5,067	100%	T2	0%	6,969
aliskiren 150 MG Oral Tablet aliskiren	5,067	100%	T3	0.3%	6,966
aliskiren 300 MG Oral Tablet aliskiren	5,067	100%	T3	0.3%	6,966
{1 (0.1 ML) (diazepam 50 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 5 MG Dose Kit]	5,067	100%	T4	25.8%	6,956
{1 (0.1 ML) (diazepam 100 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 10 MG Dose Kit]	5,067	100%	T4	25.8%	6,956
{2 (0.1 ML) (diazepam 75 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 15 MG Dose Kit]	5,067	100%	T4	25.8%	6,956
{2 (0.1 ML) (diazepam 100 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 20 MG Dose Kit]	5,067	100%	T4	25.8%	6,956
prochlorperazine 25 MG Rectal Suppository prochlorperazine	5,067	100%	T3	0%	6,848
prochlorperazine 5 MG Oral Tablet prochlorperazine	5,067	100%	T2	2.1%	6,848
prochlorperazine 10 MG Oral Tablet prochlorperazine	5,067	100%	T2	2.1%	6,848
everolimus 0.25 MG Oral Tablet everolimus	5,067	100%	T3	100%	6,726
everolimus 0.5 MG Oral Tablet everolimus	5,067	100%	T4	100%	6,726
everolimus 0.75 MG Oral Tablet everolimus	5,067	100%	T4	100%	6,726
everolimus 1 MG Oral Tablet everolimus	5,067	100%	T4	100%	6,726
everolimus 2.5 MG Oral Tablet everolimus	5,067	100%	T4	99.1%	6,726
everolimus 5 MG Oral Tablet everolimus	5,067	100%	T4	99.1%	6,726
everolimus 7.5 MG Oral Tablet everolimus	5,067	100%	T4	99.1%	6,726
everolimus 2 MG Tablet for Oral Suspension everolimus	5,067	100%	T4	99.1%	6,726
everolimus 3 MG Tablet for Oral Suspension everolimus	5,067	100%	T4	99.1%	6,726
everolimus 5 MG Tablet for Oral Suspension everolimus	5,067	100%	T4	99.1%	6,726
everolimus 10 MG Oral Tablet everolimus	5,067	100%	T4	99.1%	6,726
bromocriptine 2.5 MG Oral Tablet bromocriptine	5,067	100%	T3	0%	6,713
perampanel 0.5 MG/ML Oral Suspension [FYCOMPA] perampanel	5,067	100%	T4	39.7%	6,343
{2 (24 HR levomilnacipran 20 MG Extended Release Oral Capsule [Fetzima]) / 26 (24 HR levomilnacipran 40 MG Extended Release Oral Capsule [Fetzima]) } Pack [Fetzima Pack] levomilnacipran	5,067	100%	T3	38.5%	6,280
24 HR levomilnacipran 120 MG Extended Release Oral Capsule [Fetzima] levomilnacipran	5,067	100%	T3	38.5%	6,280
24 HR levomilnacipran 20 MG Extended Release Oral Capsule [Fetzima] levomilnacipran	5,067	100%	T3	38.5%	6,280
24 HR levomilnacipran 40 MG Extended Release Oral Capsule [Fetzima] levomilnacipran	5,067	100%	T3	38.5%	6,280
24 HR levomilnacipran 80 MG Extended Release Oral Capsule [Fetzima] levomilnacipran	5,067	100%	T3	38.5%	6,280
olaparib 100 MG Oral Tablet [Lynparza] olaparib	5,067	100%	T4	99.4%	5,974
olaparib 150 MG Oral Tablet [Lynparza] olaparib	5,067	100%	T4	99.4%	5,974
trifluoperazine 2 MG Oral Tablet trifluoperazine	5,067	100%	T2	13.6%	5,910
trifluoperazine 5 MG Oral Tablet trifluoperazine	5,067	100%	T2	13.6%	5,910
trifluoperazine 10 MG Oral Tablet trifluoperazine	5,067	100%	T2	13.6%	5,910
trifluoperazine 1 MG Oral Tablet trifluoperazine	5,067	100%	T2	13.6%	5,910
rifabutin 150 MG Oral Capsule rifabutin	5,067	100%	T3	0%	5,857
anagrelide 0.5 MG Oral Capsule anagrelide	5,067	100%	T2	0%	5,658
anagrelide 1 MG Oral Capsule anagrelide	5,067	100%	T3	0%	5,658
testosterone enanthate 200 MG/ML Injectable Solution testosterone enanthate	5,067	100%	T2	71.5%	5,120
dasatinib 20 MG Oral Tablet dasatinib	5,067	100%	T4	99.4%	5,120
dasatinib 50 MG Oral Tablet dasatinib	5,067	100%	T4	99.4%	5,120
dasatinib 70 MG Oral Tablet dasatinib	5,067	100%	T4	99.4%	5,120
dasatinib 100 MG Oral Tablet dasatinib	5,067	100%	T4	99.4%	5,120
dasatinib 80 MG Oral Tablet dasatinib	5,067	100%	T4	99.4%	5,120
dasatinib 140 MG Oral Tablet dasatinib	5,067	100%	T4	99.4%	5,120
riociguat 0.5 MG Oral Tablet [Adempas] riociguat	5,067	100%	T4	100%	4,980
riociguat 1 MG Oral Tablet [Adempas] riociguat	5,067	100%	T4	100%	4,980
riociguat 1.5 MG Oral Tablet [Adempas] riociguat	5,067	100%	T4	100%	4,980
riociguat 2 MG Oral Tablet [Adempas] riociguat	5,067	100%	T4	100%	4,980
riociguat 2.5 MG Oral Tablet [Adempas] riociguat	5,067	100%	T4	100%	4,980
tazarotene 1 MG/ML Topical Cream tazarotene	5,067	100%	T3	66.4%	4,869
carbidopa 10 MG / levodopa 100 MG Oral Tablet carbidopa	5,067	100%	T2	0%	4,842
carbidopa 25 MG / levodopa 100 MG Oral Tablet carbidopa	5,067	100%	T2	0%	4,842
carbidopa 25 MG / levodopa 250 MG Oral Tablet carbidopa	5,067	100%	T2	0%	4,842
carbidopa 50 MG / levodopa 200 MG Extended Release Oral Tablet carbidopa	5,067	100%	T2	0%	4,842
carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet carbidopa	5,067	100%	T2	0%	4,842
0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9] L1	5,067	100%	T2	1.8%	4,779
0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9] L1	5,067	100%	T2	1.8%	4,779
axitinib 1 MG Oral Tablet [Inlyta] axitinib	5,067	100%	T4	99.4%	4,739
axitinib 5 MG Oral Tablet [Inlyta] axitinib	5,067	100%	T4	99.4%	4,739
aprepitant 125 MG Oral Capsule aprepitant	5,067	100%	T3	99.7%	4,705
aprepitant 80 MG Oral Capsule aprepitant	5,067	100%	T3	99.7%	4,705
{21 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali 200 MG Daily Dose Carton] ribociclib	5,067	100%	T4	99.4%	4,543
{42 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali 400 MG Daily Dose Carton] ribociclib	5,067	100%	T4	99.4%	4,543
{63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali 600 MG Daily Dose Carton] ribociclib	5,067	100%	T4	99.4%	4,543

← Previous Page 11 of 61 Next →

Source: CMS Quarterly Prescription Drug Plan Formulary PUF 2026. 6,046 drugs with RXCUI identifiers from NLM RxNorm. Coverage percentages based on 0 active Part D plans.

Compiled by Plainmedicare Editorial, Health Insurance Editorial Team